Drug profile · INN
imipramine hydrochloride
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride (IMIPRAMINE HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — imipramine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 1
- Programs
- 4
- Data quality
- 0.89
Quick answer
imipramine hydrochloride (IMIPRAMINE HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is imipramine hydrochloride?
imipramine hydrochloride (IMIPRAMINE HYDROCHLORIDE) is a serotonin transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for imipramine hydrochloride?
IMIPRAMINE HYDROCHLORIDE is a marketed brand name for imipramine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of imipramine hydrochloride?
imipramine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.